Emprise Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$324K Sell
1,237
-136
-10% -$34.9K 0.12% 76
2026
Q2
$346K Hold
1,373
– – 0.13% 78
2026
Q1
$299K Hold
1,373
– – 0.12% 80
2025
Q4
$314K Sell
1,373
-1
-0.1% -$228 0.13% 78
2025
Q3
$318K Buy
1,374
+36
+3% +$7.33K 0.14% 79
2025
Q2
$248K Sell
1,338
-105
-7% -$19.5K 0.12% 90
2025
Q1
$302K Sell
1,443
-191
-12% -$37.1K 0.16% 76
2024
Q4
$290K Sell
1,634
-498
-23% -$91.6K 0.16% 83
2024
Q3
$421K Sell
2,132
-951
-31% -$177K 0.24% 68
2024
Q2
$529K Sell
3,083
-1,072
-26% -$178K 0.33% 65
2024
Q1
$757K Hold
4,155
– – 0.51% 50

Other funds holding ABBV

Emprise Bank's ABBV Position: Q3 2026 in Review

Emprise Bank reduced its AbbVie (ABBV) stake by 9.9% in Q3 2026, selling an estimated $34.9K and leaving 1,237 shares worth $324K. The position accounts for 0.12% of the portfolio, ranked #76.

Emprise Bank first reported a position in ABBV in Q1 2024 and has held it in 11 quarters since. The position peaked at $757K in Q1 2024. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Emprise Bank held 1,237 shares of AbbVie worth $324K as of Q3 2026.
  • Emprise Bank sold 136 AbbVie shares in Q3 2026, an estimated $34.9K.
  • AbbVie made up 0.12% of Emprise Bank's portfolio in Q3 2026, its #76 holding.
  • Emprise Bank first reported a position in AbbVie in Q1 2024 and has held it in 11 quarters since.
  • Emprise Bank's AbbVie position peaked at $757K in Q1 2024.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Emprise Bank's 13F filing for Q3 2026, filed 7 Oct 2026.